IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants
IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants
IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants
Human medicines European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), aripiprazole, Date of authorisation: 30/06/2015, Revision: 18, Status: Authorised
Agenda of the CAT meeting 22-24 May 2024
EMEA-003273-PIP02-22
EMEA-003090-PIP02-22
EMEA-003355-PIP01-22
EMEA-002247-PIP03-17-M01
EMA confirms recommendation for non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
Medical devices: new guidance for industry and notified bodies
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)